Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Whole-Body FDG PET/CT Radiomics as a Biomarker of True Oligometastatic Disease in Breast Cancer.

NCT07872332 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT07872332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07872332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Whole-Body FDG PET/CT Radiomics as a Biomarker of True Oligometastatic Disease in Breast Cancer.
Lead sponsor
Sohag University
Phase
Observational
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
October 1, 2027
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

oligometastatic breast carcinoma, radiomics